I-PromaCare-TA / Tranexamic Acid

I-PromaCare-TA / Tranexamic Acid Isithombe Esifakiwe
  • I-PromaCare-TA / Tranexamic Acid

Incazelo emfushane:

I-PromaCare-TA iyisidakamizwa esijwayelekile, i-ejenti ye-antifibrinolytic ebalulekile ohlwini lwe-WHO. Isetshenziswe njengomuthi wendabuko we-hemostatic.Iwumuthi wokuvinjelwa kwe-plasminogen ku-plasmin egazini. I-Tranexamic acid ivimbela ngokuncintisana ukusebenza kwe-plasminogen (ngokubophezela kusizinda se-kringle), ngaleyo ndlela yehlise ukuguqulwa kwe-plasminogen ku-plasmin (fibrinolysin), i-enzyme eyehlisa amahlule e-fibrin, i-fibrinogen, namanye amaprotheni e-plasma, okuhlanganisa izici ze-procoagulant V kanye ne-VIII. I-Tranexamic acid iphinde ivimbele ngokuqondile ukusebenza kwe-plasmin, kodwa imithamo ephezulu iyadingeka kunaleyo edingekayo ukuze kwehliswe ukwakheka kwe-plasmin.


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

 

Igama lokuhweba I-PromaCare-TA
I-CAS 1197-18-8
Igama Lomkhiqizo I-Tranexamic Acid
Isakhiwo Samakhemikhali
Isicelo Umuthi
Iphakheji 25kgs inetha isigubhu ngasinye
Ukubukeka Amandla amhlophe noma acishe abe mhlophe, ayikristalu
Isivivinyo 99.0-101.0%
Ukuncibilika Amanzi ancibilikayo
Impilo yeshelufu 4 iminyaka
Isitoreji Gcina isitsha sivalwe ngokuqinile futhi endaweni epholile. Gcina kude nokushisa.

Isicelo

I-Tranexamic Acid, eyaziwa nangokuthi i-clotting acid, iyi-antifibrinolytic amino acid, engenye yama-anticoagulants asetshenziswa kakhulu emtholampilo.

Lo mkhiqizo ungasetshenziselwa:

1. Ukuhlukumezeka noma ukopha ngokuhlinzwa kwe-prostate, urethra, amaphaphu, ubuchopho, isibeletho, indlala ye-adrenal, indlala yegilo, isibindi nezinye izitho ezicebile nge-activator ye-plasminogen.

2. Asetshenziswa njengama-ejenti we-thrombolytic, njenge-tissue plasminogen activator (t-PA), i-streptokinase kanye ne-urokinase antagonist.

3. Ukukhipha isisu okubangelwayo, ukukhishwa kwe-placenta, ukuzala umntwana oshonile kanye ne-amniotic fluid embolism okubangelwa ukopha kwe-fibrinolytic.

4. I-Menorrhagia, ukopha kwe-anterior chamber kanye ne-epistaxis enzima ngokukhuphuka kwe-fibrinolysis yendawo.

5. Isetshenziselwa ukuvimbela noma ukunciphisa ukopha ngemva kokukhipha izinyo noma ukuhlinzwa ngomlomo ezigulini ezine-hemophilic ezine-factor VIII noma ukuntuleka kwe-factor IX.

6. Lo mkhiqizo uphakeme kunezinye izidakamizwa ze-antifibrinolytic ku-hemostasis yokopha okuncane okubangelwa ukugqashuka kwe-aneurysm emaphakathi, njengokuphuma kwe-subarachnoid hemorrhage kanye ne-intracranial aneurysm hemorrhage. Kodwa-ke, kufanele kuqashelwe ingozi ye-cerebral edema noma i-cerebral infarction. Ngokuqondene neziguli ezinzima ezinezinkomba zokuhlinzwa, lo mkhiqizo ungasetshenziswa kuphela njenge-adjuvant.

7. Ukuze ukwelashwa kwe-edema ye-vascular hereditary, kunganciphisa inani lokuhlaselwa nokuqina.

8. Iziguli ezine-hemophilia zopha okusebenzayo.

9. Inomphumela oqondile wokwelapha ku-chloasma.

  • Okwedlule:
  • Olandelayo:

    • IMIKHIQIZO EHLOBANE